I-028

Interference Mix 6

5-100 μg/mL each component in methanol, Cerilliant^®

• 同義詞: Qualitative Interference Mixture
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• 等級: analytical standard
• 品質等級: 100
• 形狀: liquid
• 成份: Amlodipine besylate, 5 μg/mL (as free base); Atorvastatin calcium salt, 100 μg/mL (as free base); Azithromycin dihydrate, 100 μg/mL (as free base); Bupivacaine hydrochloride monohydrate, 100 μg/mL (as free base); Cetirizine dihydrochloride, 50 μg/mL (as free base); Dimenhydrinate, 100 μg/mL ; Lisinopril dihydrate, 100 μg/mL (as free base); Loratadine, 100 μg/mL
• 包裝: ampule of 1 mL
• 製造商／商標名: Cerilliant^®
• 濃度: 5-100 μg/mL each component in methanol
• 技術: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 應用: forensics and toxicology
• 形式: single component solution
• 儲存溫度: −20°C

描述

一般說明

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs amlodipine, atorvastatin, cetirizine, azithromycin, bupivacaine, dimenhydrinate, lisinopril, and loratidine. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 象形圖: GHS02,GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H225,H301 + H311 + H331,H370
• 防範說明: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• 危險分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• 標靶器官: Eyes,Central nervous system
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: 49.5 °F - closed cup
• 閃點（°C）: 9.7 °C - closed cup